JP2024526156A5 - - Google Patents
Info
- Publication number
- JP2024526156A5 JP2024526156A5 JP2023578894A JP2023578894A JP2024526156A5 JP 2024526156 A5 JP2024526156 A5 JP 2024526156A5 JP 2023578894 A JP2023578894 A JP 2023578894A JP 2023578894 A JP2023578894 A JP 2023578894A JP 2024526156 A5 JP2024526156 A5 JP 2024526156A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclopropyl
- methyl
- ethyl
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110694497.1 | 2021-06-22 | ||
| CN202110694497 | 2021-06-22 | ||
| CN202210002094.0 | 2022-01-04 | ||
| CN202210002094 | 2022-01-04 | ||
| CN202210665753 | 2022-06-13 | ||
| CN202210665753.9 | 2022-06-13 | ||
| PCT/CN2022/100435 WO2022268119A1 (zh) | 2021-06-22 | 2022-06-22 | 亚磺酰亚胺类化合物及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526156A JP2024526156A (ja) | 2024-07-17 |
| JP2024526156A5 true JP2024526156A5 (enExample) | 2025-06-30 |
Family
ID=84545187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023578894A Pending JP2024526156A (ja) | 2021-06-22 | 2022-06-22 | スルホキシイミン化合物およびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240376093A1 (enExample) |
| EP (1) | EP4361138A4 (enExample) |
| JP (1) | JP2024526156A (enExample) |
| KR (1) | KR20240024906A (enExample) |
| CN (1) | CN117500796B (enExample) |
| AU (1) | AU2022298616A1 (enExample) |
| BR (1) | BR112023026964A2 (enExample) |
| CA (1) | CA3223641A1 (enExample) |
| IL (1) | IL309572A (enExample) |
| MX (1) | MX2023015440A (enExample) |
| TW (1) | TWI825800B (enExample) |
| WO (1) | WO2022268119A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120239699A (zh) * | 2022-12-22 | 2025-07-01 | 祐森健恒生物医药（上海）有限公司 | 一种吡啶多取代化合物的盐型、晶型及其制备方法 |
| WO2025186427A1 (en) * | 2024-03-08 | 2025-09-12 | Curia Spain, S.A.U. | Process for the preparation of deucravacitinib and intermediates thereof and method for purifying deucravacitinib |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3495358T (lt) * | 2012-11-08 | 2022-05-25 | Bristol-Myers Squibb Company | Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai |
| CN111936486B (zh) * | 2018-03-22 | 2023-09-22 | 百时美施贵宝公司 | 用作IL-12、IL-23和/或IFNα响应的调节剂的包含吡啶的杂环化合物 |
| JP7631193B2 (ja) * | 2018-10-22 | 2025-02-18 | アルミス インコーポレイテッド | Ｔｙｋ２阻害剤およびその使用 |
| AU2019373203B2 (en) * | 2018-10-30 | 2024-10-24 | Bristol-Myers Squibb Company | Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha |
| CN213366611U (zh) * | 2018-11-05 | 2021-06-04 | 深圳市优行新能源有限公司 | 光伏组件 |
| SG11202108162SA (en) * | 2019-01-30 | 2021-08-30 | Bristol Myers Squibb Co | Amide-disubstituted pyridine or pyridazine compounds |
| AU2021254764A1 (en) * | 2020-04-14 | 2022-11-03 | Gossamer Bio Services, Inc. | Substituted pyridines for the treatment of inflammatory diseases |
| KR20230004771A (ko) * | 2020-04-28 | 2023-01-06 | 브리스톨-마이어스 스큅 컴퍼니 | Il-12, il-23 및/또는 ifn알파 조정제로서의 치환된 n-(메틸-d3)피리다진-3-카르복스아미드 또는 n-(메틸-d3)-니코틴아미드 화합물 |
| TW202227430A (zh) * | 2020-11-17 | 2022-07-16 | 大陸商江蘇恆瑞醫藥股份有限公司 | 含氮雜環類衍生物、其製備方法及其在醫藥上的應用 |
-
2022
- 2022-06-22 CA CA3223641A patent/CA3223641A1/en active Pending
- 2022-06-22 US US18/573,074 patent/US20240376093A1/en active Pending
- 2022-06-22 EP EP22827611.9A patent/EP4361138A4/en active Pending
- 2022-06-22 CN CN202280043560.8A patent/CN117500796B/zh active Active
- 2022-06-22 AU AU2022298616A patent/AU2022298616A1/en active Pending
- 2022-06-22 TW TW111123283A patent/TWI825800B/zh active
- 2022-06-22 MX MX2023015440A patent/MX2023015440A/es unknown
- 2022-06-22 WO PCT/CN2022/100435 patent/WO2022268119A1/zh not_active Ceased
- 2022-06-22 IL IL309572A patent/IL309572A/en unknown
- 2022-06-22 BR BR112023026964A patent/BR112023026964A2/pt unknown
- 2022-06-22 JP JP2023578894A patent/JP2024526156A/ja active Pending
- 2022-06-22 KR KR1020247001056A patent/KR20240024906A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7106462B2 (ja) | Ｎ－（ヘテロアリール）－ピロロ［３，２－ｄ］ピリミジン－２－アミンの合成 | |
| WO2022105857A1 (en) | Kras g12d inhibitors | |
| JP2018534257A5 (enExample) | ||
| CA3246028A1 (en) | KIF18A INHIBITOR | |
| ES2916805T3 (es) | Síntesis de derivados de isoxazolina espirocíclicos | |
| CN120265621A (zh) | 一类螺环衍生物作为kif18a抑制剂 | |
| FR2921657A1 (fr) | Derives de nicotinamide, leur preparation et leur application en therapeutique | |
| KR20220133189A (ko) | 4-발레릴옥시부티르산의 합성 방법 | |
| JP2024536353A (ja) | Ｇｌｐ－１受容体修飾因子と特定の２，５－ジアザビシクロ［４．２．０］オクタン | |
| JP2024526156A5 (enExample) | ||
| CN107365275B (zh) | 高纯度的赛乐西帕 | |
| EA038078B1 (ru) | Промежуточные соединения, используемые для синтеза селективного ингибитора протеинкиназы, и способы их получения | |
| TWI359135B (en) | Organic compounds | |
| KR20250170688A (ko) | Ras 저해제의 합성 | |
| CN106456645B (zh) | 用于放射性标记的方法和试剂 | |
| CN103342707B (zh) | 用于制备阿塞纳平中间体的制备方法 | |
| US12006291B2 (en) | Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid | |
| EP3892615A1 (en) | Process for the preparation of silodosin | |
| JP2011057665A (ja) | 光学活性な１−アミノ−２−ビニルシクロプロパンカルボン酸エステルの製造方法 | |
| CN103709101A (zh) | 一类renierramycin G的合成中间体及其制备方法 | |
| JP2024515985A (ja) | ６員芳香族ヘテロ尿素環の誘導体及びその使用 | |
| CN114057769A (zh) | 大环哒嗪类化合物及其用途 | |
| CN108727214B (zh) | 一种麻醉剂丁哌卡因杂质的合成方法 | |
| CN111527069A (zh) | 一类喹啉衍生物 | |
| CN115515958B (zh) | 一种新型磺酰胺类menin-MLL相互作用抑制剂、其制备方法及医药用途 |